Current Neurology and Neuroscience Reports

, Volume 9, Issue 2, pp 91–93

An oral calcitonin gene-related peptide receptor antagonist for acute migraine management: Sign of a possible new chapter in headache medicine

  • Ivan Garza
Clinical Trials Report
  • 33 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Doenicke A, Brand J, Perrin VL: Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988, 1(8598):1309–1311.PubMedCrossRefGoogle Scholar
  2. 2.
    Ferrari MD, Rn KI, Lipton RB, Goadsby PJ: Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001, 358:1668–1675.PubMedCrossRefGoogle Scholar
  3. 3.
    Garza I, Swanson JW: Answers to frequently asked questions about migraine. Mayo Clin Proc 2006, 81:1387–1391; quiz 1392.PubMedCrossRefGoogle Scholar
  4. 4.
    Goadsby PJ, Lipton RB, Ferrari MD: Migraine—current understanding and treatment. N Engl J Med 2002, 346:257–270.PubMedCrossRefGoogle Scholar
  5. 5.
    Goadsby PJ, Edvinsson L, Ekman R: Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988, 23:193–196.PubMedCrossRefGoogle Scholar
  6. 6.
    Zagami AS, Goadsby PJ, Edvinsson L: Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990, 16:69–75.PubMedCrossRefGoogle Scholar
  7. 7.
    Lassen LH, Haderslev PA, Jacobsen VB, et al.: CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48–56.PubMedCrossRefGoogle Scholar
  9. 9.
    Olesen J, Diener HC, Husstedt IW, et al.: Calcitonin generelated peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004, 350:1104–1110.PubMedCrossRefGoogle Scholar
  10. 10.
    Petersen KA, Birk S, Lassen LH, et al.: The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2005, 25:139–147.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Ivan Garza

There are no affiliations available

Personalised recommendations